Ajanta Pharma clarified that there is no import alert by US FDA on our facility or any of our products approved by USFDA.
The company stated that it appears that some unknown and unrelated entity/individual has sent some Sildenafil manufactured by Ajanta Pharma being sold in India or other emerging market to USA.
We have no relations or connection to this dispatch of Sildenafil to USA. US authorities have seized this product as it is not approved by US FDA, the company added.
The company added that it once again clarify that there is no import alert on our facility or any of our products
approved by US FDA and we continue to supply the products to US.
Earlier, the company announced the receipt of final approval for Duloxetine Hydrochloride Delayed Release Capsules from US FDA. It is a bioequivalent generic version of Cymbalta Delayed Release Capsules.